Quantitative single-cell functional characterization of CD19-specific chimeric antigen receptor T cells

被引：0

作者：

Varadarajan, Navin ^{[1
]}

Liadi, Ivan ^{[1
]}

Romain, Gabrielle ^{[1
]}

Singh, Harjeet ^{[2
]}

Cooper, Laurence ^{[2
]}

机构：

[1] Univ Houston, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF IMMUNOLOGY | 2013年 / 190卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P4344

引用

页数：1

共 50 条

[41] Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy
Bhoj, Vijay
Milone, Michael C.
June, Carl H.
Porter, David
Grupp, Stephan A.
Melenhorst, Jan J.
Lacey, Simon F.
Callahan, Colleen
Capobianchi, James
Wertheim, Gerald
Mahnke, Yolanda
BLOOD, 2014, 124 (21)
[42] Subcutaneous Immunoglobulin Replacement Following CD19-Specific Chimeric Antigen Receptor-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia
Arnold, Danielle E.
Callahan, Colleen A.
Maude, Shannon L.
Grupp, Stephan A.
Heimall, Jennifer
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S145 - S146
[43] Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies
Castellanos-Rueda, Rocio
Di Roberto, Raphael B.
Schlatter, Fabrice S.
Reddy, Sai T.
TRENDS IN BIOTECHNOLOGY, 2021, 39 (12) : 1308 - 1320
[44] Applications of single-cell omics for chimeric antigen receptor T cell therapy
Ghaffari, Sasan
Saleh, Mahshid
Akbari, Behnia
Ramezani, Faezeh
Mirzaei, Hamid Reza
IMMUNOLOGY, 2024, 171 (03) : 339 - 364
[45] shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia
Kang, Liqing
Tang, Xiaowen
Xu, Nan
Li, Minghao
Tan, Jingwen
Qi, Wei
Yu, Zhou
Lou, Xiaoyan
Xue, Shengli
Li, Xin
Zhang, Jian
Chen, Jia
Wang, Zhenkun
Li, Caixia
Cheng, Fu Cheng
Wu, Depei
Yu, Lei
BLOOD, 2019, 134
[46] Novel Antigen-Specific Expansion of T Cells Transduced with a CD19 Chimeric Antigen Receptor
Lee, Daniel W.
Kochenderfer, James N.
Rader, Christoph
Orentas, Rimas J.
Mackall, Crystal L.
BLOOD, 2010, 116 (21) : 1337 - 1337
[47] Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy
Berger, Susanna Carolina
Fehse, Boris
Akyuz, Nuray
Geffken, Maria
Wolschke, Christine
Janson, Dietlinde
Gagelmann, Nico
Luther, Marlene
Wichmann, Dominic
Frenzel, Christian
Thayssen, Guenther
Alegiani, Anna
Badbaran, Anita
Zeschke, Silke
Dierlamm, Judith
Kroger, Nicolaus
Ayuk, Francis A.
HAEMATOLOGICA, 2023, 108 (02) : 444 - 456
[48] T Cells Expressing CD19-Specific Chimeric Antigen Receptors Are Inhibited By Indoleamine 2,3-Dioxygenase in Tumors
Ninomiya, Soranobu
Huye, Leslie E.
Savoldo, Barbara
Dotti, Gianpietro
Heslop, Helen E.
Brenner, Malcolm K.
Rooney, Cliona M.
Ramos, Carlos A.
BLOOD, 2014, 124 (21)
[49] CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells
Kowolik, Claudia M.
Topp, Max S.
Gonzalez, Sergio
Pfeiffer, Timothy
Olivares, Simon
Gonzalez, Nancy
Smith, David D.
Forman, Stephen J.
Jensen, Michael C.
Cooper, Laurence J. N.
CANCER RESEARCH, 2006, 66 (22) : 10995 - 11004
[50] Functional Characterization and Optimization of Switchable Allogeneic Chimeric Antigen Receptor T Cells for Targeting CD19 and CD20 in B Cell Malignancies
Spehr, Johannes
Meyer, Jan-Erik
Loff, Simon
Langer, Anika
Langer, Moritz
Boyerinas, Ben
Le Mercier, Isabelle
Lescarbeau, Reynald
Cartellieri, Marc
Ehninger, Armin
BLOOD, 2023, 142

← 1 2 3 4 5 →